![]() | This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Archive 1 |
There is also another treatment (licensed in Europe and other countries) called Agalsidase-A (Replagal).
I was involved in running the alpha-gal A trials in the UK. If I can help with this page (without breaching my confidentiality agreement with TKT) let me know. -- Amdsweb 12:50, 3 March 2006 (UTC)
Narrative review in Ann Intern Med this week: PMID 17371887. JFW | T@lk 16:34, 21 March 2007 (UTC)
There appears to be no apostrophe 's in this disease's name.
It shoudl be placed back at Fabry disease. Even google knows how to spell it [1].
(Interstingly Google actually has just under 10,000 more hits for "Fabry's disease" than " Fabry disease". Is that all wikipedia's fault?)
Anyone objecting to moving.-- ZayZayEM ( talk) 03:14, 30 October 2008 (UTC)
Other references checked also indicate that the proper name is "Fabry disease" so it should be moved. —Preceding unsigned comment added by 216.134.203.4 ( talk) 21:14, 16 April 2009 (UTC)
I have just read the opening paragraph and I have no more idea what this disease is than I had before I looked it up.
Anyone who understands that paragraph doesn't need to read a Wikipedia article about it.
Cannonmc ( talk) 13:08, 14 June 2015 (UTC)
I agree that the opening sentences difficult. I rearranged the structure, without changing content. I think this will help. I think that the concepts of 'lysosomal storage disease' ,'X linked' and 'sphingolipidosis' are best left to their related pages,rather than expanding here. 09:42, 1 January 2018 (UTC) — Preceding unsigned comment added by Jhunt29 ( talk • contribs)
Hello fellow Wikipedians,
I have just modified one external link on Fabry disease. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018.
After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than
regular verification using the archive tool instructions below. Editors
have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the
RfC before doing mass systematic removals. This message is updated dynamically through the template {{
source check}}
(last update: 5 June 2024).
Cheers.— InternetArchiveBot ( Report bug) 09:47, 27 September 2017 (UTC)
![]() | This is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Archive 1 |
There is also another treatment (licensed in Europe and other countries) called Agalsidase-A (Replagal).
I was involved in running the alpha-gal A trials in the UK. If I can help with this page (without breaching my confidentiality agreement with TKT) let me know. -- Amdsweb 12:50, 3 March 2006 (UTC)
Narrative review in Ann Intern Med this week: PMID 17371887. JFW | T@lk 16:34, 21 March 2007 (UTC)
There appears to be no apostrophe 's in this disease's name.
It shoudl be placed back at Fabry disease. Even google knows how to spell it [1].
(Interstingly Google actually has just under 10,000 more hits for "Fabry's disease" than " Fabry disease". Is that all wikipedia's fault?)
Anyone objecting to moving.-- ZayZayEM ( talk) 03:14, 30 October 2008 (UTC)
Other references checked also indicate that the proper name is "Fabry disease" so it should be moved. —Preceding unsigned comment added by 216.134.203.4 ( talk) 21:14, 16 April 2009 (UTC)
I have just read the opening paragraph and I have no more idea what this disease is than I had before I looked it up.
Anyone who understands that paragraph doesn't need to read a Wikipedia article about it.
Cannonmc ( talk) 13:08, 14 June 2015 (UTC)
I agree that the opening sentences difficult. I rearranged the structure, without changing content. I think this will help. I think that the concepts of 'lysosomal storage disease' ,'X linked' and 'sphingolipidosis' are best left to their related pages,rather than expanding here. 09:42, 1 January 2018 (UTC) — Preceding unsigned comment added by Jhunt29 ( talk • contribs)
Hello fellow Wikipedians,
I have just modified one external link on Fabry disease. Please take a moment to review my edit. If you have any questions, or need the bot to ignore the links, or the page altogether, please visit this simple FaQ for additional information. I made the following changes:
When you have finished reviewing my changes, you may follow the instructions on the template below to fix any issues with the URLs.
This message was posted before February 2018.
After February 2018, "External links modified" talk page sections are no longer generated or monitored by InternetArchiveBot. No special action is required regarding these talk page notices, other than
regular verification using the archive tool instructions below. Editors
have permission to delete these "External links modified" talk page sections if they want to de-clutter talk pages, but see the
RfC before doing mass systematic removals. This message is updated dynamically through the template {{
source check}}
(last update: 5 June 2024).
Cheers.— InternetArchiveBot ( Report bug) 09:47, 27 September 2017 (UTC)